Vistagen Therapeutics (VTGN) Q1 2025 Earnings

13FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.51
-0.24
0.03
0.3

Details

Expected EPS
-0.509675
Actual EPS
-0.46
Surprise EPS
0.05
Surprise Percent
+9.75%

Description

Vistagen Therapeutics (VTGN) has reported earnings of -0.46 per share for Q1 2025.

0 Comments

Share your thoughts